(Q40456758)

English

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

scientific article published on March 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. (English)
Robert H Vonderheide
Molly S Stumacher
Natalie A Hutnick
Patricia Sullivan
J Joseph Mahany
Stephanie J Green
Peter J O'Dwyer
Kelli L Running
Richard D Huhn
Scott J Antonia

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit